EX-99.1 2 drr0688_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,

India.

CIN : L85195TG1984PLC004507

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

November 4, 2024

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Ltd. (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 

This is to inform that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company at its meeting held on November 4, 2024, has approved the grant of stock options to the eligible employees under the Employees Stock Option Schemes of the Company:

 

Sl. No.

Type of

Option(s)

Number

of options

granted

 Value

Exercise

Price per

share

 ESOP Scheme
1 Indian Stock Options *4,820 Fair Market Value Rs. 1,274/- Dr. Reddy’s Employees Stock Option Scheme, 2018
*Equally graded vesting in 4 years.

 

This is for your information and records.

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

 

K. Randhir Singh

Company Secretary, Compliance Officer & Head-CSR